Unlocking the Potential: Neurovascular Devices Market Projected to Reach $7.0 Billion by 2033, According to Transparency Market Research Inc.

Unlocking the Potential: Neurovascular Devices Market Projected to Reach $7.0 Billion by 2033, According to Transparency Market Research Inc. Rise in inclination toward the usage of minimally invasive technologies for the treatment of neurovascular diseases is driving growth in the neurovascular devices market When it comes to advancements in medical technology, the field of neurovascular…

Read More

Get Ready to Crunch the Numbers: CrossAmerica Partners Spills the Beans on 2022 Earnings!

Hey there, fellow financial enthusiasts! Get ready for some exciting news from CrossAmerica Partners! So, guess what? CrossAmerica Partners LP (NYSE: CAPL) just dropped the bomb that they will be unveiling their fourth quarter and full year 2022 financial results on February 27th, 2023. Can you feel the suspense building up already? This announcement has…

Read More

Get Your Wallets Ready: Akoustis Drops the Deets on Their $30 Million Stock Offering!

Welcome to the Akoustis Announces Pricing of Public Offering Blog Post! Breaking News Alert: Hey there, tech-savvy readers! Have you heard the latest news coming out of Charlotte, N.C.? Akoustis Technologies, Inc. just revealed some exciting updates about their recent public offering of common stock. Hold onto your hats, because this announcement is about to…

Read More

Attention Y-mAbs Investors: Important Class Action Lawsuit Update from Kaplan Fox Kilsheimer LLP

Kaplan Fox & Kilsheimer LLP Investigates Claims on Behalf of Y-mAbs Investors NEW YORK, Jan. 19, 2023 (GLOBE NEWSWIRE) — Kaplan Fox & Kilsheimer LLP is continuing its investigation of claims on behalf of investors in Y-mAbs Therapeutics, Inc. (“Y-mAbs” or the “Company”) (NASDAQ: YMAB) stock. A complaint has been filed on behalf of investors…

Read More